RESUMO
Investigative studies dealing with the properties and functions of endothelial cells have been hampered because there has been little or no success in the isolation, growth, and passage of individual cells in large numbers. We have developed a system whereby pure cultures of endothelial cells derived from umbilical veins can be subcultured for at least five serial passages. Many facets of endothelial function and interaction can be evaluated with the use of this new adaptive system of isolation and culture.
Assuntos
Células Cultivadas , Células Epiteliais , Divisão Celular , Meios de Cultura , Endotélio/citologia , Técnica de Congelamento e Réplica , Humanos , Microscopia Eletrônica , Veias Umbilicais/citologiaRESUMO
An in vitro method was used to detect adherence of (51)Cr-labeled platelets to monolayers of cultured human endothelial, fibroblast, and smooth muscle cells. Washed platelets did not adhere to untreated or aspirin-treated endothelial monolayers in the absence of thrombin. In contrast, thrombin-induced platelet aggregates adhered to all of the monolayers but adherence to endothelium was significantly less than to the other cells. Additional evidence for adherence of platelets to the endothelium was provided by scanning and transmission electron microscopy. Thrombin-induced platelet adherence to endothelium was inhibited by hirudin. Platelet adherence induced by thrombin was enhanced significantly by treatment of the endothelial monolayer with 1-2 mM aspirin. This increase in adherence was seen even when aspirin-treated platelets were used; adherence values approached those seen with fibroblasts and smooth muscle cells. An aspirin concentration of 0.1 mM was sufficient to block thrombin-induced malonaldehyde production in platelets but it did not interfere with the inhibitory effect of the endothelium against platelet adherence. The effect of aspirin on the endothelium was temporary and inhibitory activity of the endothelium was restored 1 h after aspirin had been removed from the incubation system. The ability of thrombin to cause adherence of platelets to undamaged endothelium, and the potential for aspirin to enhance this adherence have implications for mechanisms which operate in platelet interaction with the blood vessel wall.
Assuntos
Aspirina/farmacologia , Vasos Sanguíneos/fisiologia , Adesividade Plaquetária/efeitos dos fármacos , Vasos Sanguíneos/citologia , Células Cultivadas , Endotélio/fisiologia , Fibroblastos/fisiologia , Músculo Liso/fisiologia , Agregação Plaquetária/efeitos dos fármacos , Trombina/metabolismoRESUMO
There was a rapid net uptake of free fatty acid (FFA) by human platelets when long-chain FFA, bound to human serum albumin, were incubated with platelet suspensions. Results from experiments in which both palmitate and albumin were labeled indicated that the fatty acid dissociated from the protein during uptake. Much of the FFA taken up by the platelet in short-term incubations remained in unesterified form, i.e., it was recovered as platelet FFA. As the incubation continued, increasing amounts of FFA were oxidized to CO(2) and incorporated into platelet lipid esters, particularly lecithin. Essentially all of the fatty acid that was incorporated into the platelet FFA fraction was released rapidly from the cells when they were exposed to a medium containing FFA-free albumin. The magnitude of uptake into the platelet FFA fraction was similiar at 0 degrees and 37 degrees C. Likewise, the rate and magnitude of FFA release from the platelet were similar at 0 degrees and 37 degrees C. Therefore, it is likely that both FFA uptake and FFA release occur by energy-independent mechanisms. The major effect of increasing the FFA concentration of the incubation medium was increased fatty acid uptake into the platelet FFA fraction. Similar results occurred when platelets were incubated in human plasma containing increasing amounts of added palmitate. At a given extracellular FFA concentration, considerably more of the saturated fatty acids, palmitate and stearate, were taken up as platelet FFA than either oleate or linoleate.
Assuntos
Plaquetas/metabolismo , Ácidos Graxos não Esterificados/sangue , Ácidos Linoleicos/sangue , Ácidos Oleicos/sangue , Ácidos Palmíticos/sangue , Fosfatidilcolinas/sangue , Ligação Proteica , Albumina Sérica , Ácidos Esteáricos/sangueRESUMO
When cultured human umbilical vein endothelial cells are supplemented with linoleic acid, the arachidonic acid content of the cellular phospholipids is reduced approximately 35%. Most of the fatty acid compositional change occurs during the first 24 h. One factor responsible for this effect is the inability of the endothelial cells to convert appreciable amounts of linoleic to arachidonic acid, due to a fatty acid delta 6-desaturase deficiency. By contrast, these endothelial cultures contain delta 5- and delta 9-desaturase activity and are able to elongate long-chain polyunsaturated fatty acids. The other factor that contributes to the decrease in arachidonic acid is that high concentrations of linoleic acid reduce the incorporation of arachidonate into cellular phospholipids. Stearic acid, a long-chain saturate, does not produce any reduction, whereas eicosatrienoic acid is an even more effective inhibitor than linoleic acid. In spite of the fact that high concentrations of these polyunsaturates produced inhibition, the endothelial cells were found to efficiently incorporate exogenous arachidonic acid into cellular phospholipids and triglycerides. This may serve to compensate for the inability of these cells to synthesize arachidonic acid from linoleic acid. These findings suggest that the endothelium obtains arachidonic acid from an extracellular source, that this cannot be provided in the form of linoleic acid and, in fact, that high concentrations of linoleic acid actually may interfere with the ability of the endothelium to maintain an adequate supply of intracellular arachidonic acid.
Assuntos
Ácidos Araquidônicos/metabolismo , Endotélio/metabolismo , Ácidos Linoleicos/metabolismo , Ácido Araquidônico , Células Cultivadas , Ácidos Graxos/metabolismo , Humanos , Ácido Linoleico , Lipídeos de Membrana/biossíntese , Fosfolipídeos/biossíntese , Fosfolipídeos/metabolismo , Relação Estrutura-AtividadeRESUMO
We have investigated whether changes in cellular fatty acid saturation can influence prostacyclin (PGI2) production by cultured human umbilical vein endothelial cells. As compared to control cells, those enriched with linoleic acid released 60--75% less PGI2 in response to thrombin or the calcium ionophore A23187. A similar but considerably smaller effect was observed when the cells were enriched with oleic or linolenic acid, but no reduction occurred with palmitic or linoelaidic acids. Some reduction in PGI2 release was noted as early as 1 h after exposure to linoleic acid. When the culture medium was supplemented with linoleic acid, the cell phospholipids contained four to five times more linoleate and 25--40% less arachidonate. These changes were most marked in the choline and serine plus inositol phosphoglyceride fractions. When the fatty acid composition of the cells enriched with linoleic acid was allowed to revert, there was a progressive increase in the capacity of the cells to release PGI2 in response to thrombin. The increase correlated with a reduction in linoleate content of the cell lipids, but there was no change in arachidonate content. This suggests that linoleic acid may act as an inhibitor of PGI2 production. The cultured endothelial cells were also able to produce PGI2 directly from added arachidonic acid. As the arachidonic acid concentration of the medium was raised, PGI2 formation by the linoleate-enriched cells increased relative to control cells, suggesting that the inhibition produced by linoleic acid may be competitive.
Assuntos
Endotélio/metabolismo , Epoprostenol/biossíntese , Ácidos Graxos/metabolismo , Prostaglandinas/biossíntese , Ácidos Araquidônicos/metabolismo , Calcimicina/farmacologia , Células Cultivadas , Endotélio/citologia , Humanos , Ácidos Linoleicos/metabolismo , Metabolismo dos Lipídeos , Trombina/farmacologia , Fatores de TempoRESUMO
Triiodothyronine (liothyronine sodium) (400-500 mug/day for 14 days) was given to six normal subjects. Factor VIII (antihemophilic globulin) activity increased from 109 to 167% (P < 0.05); fibrinogen increased from 344 to 581 mg/100 ml (P < 0.01). To test whether the increases in factor VIII activity and fibrinogen were mediated by beta adrenergic receptors, propranolol (20 mg every 6 hr) was given orally to four other normal subjects in addition to triiodothyronine for 14 days. Factor VIII increased from 100 to 161%; fibrinogen increased from 374 to 564% (P < 0.01). Factor VIII activity did not change in a severe classical hemophiliac made hypermetabolic with triiodothyronine, but it increased from 39 to 82% in a patient with von Willebrand's disease. Triiodothyronine-induced hypermetabolism increased the incorporation of selenomethionine-(75)Se into plasma fibrinogen. These results suggest that the increases in clotting factor activity during triiodothyronine-induced hypermetabolism reflect an effect of increased protein synthesis rather than enhanced stimulation of beta adrenergic receptors.
Assuntos
Metabolismo Basal/efeitos dos fármacos , Fator VIII/metabolismo , Fibrinogênio/metabolismo , Células Receptoras Sensoriais/efeitos dos fármacos , Tri-Iodotironina/farmacologia , Epinefrina/farmacologia , Fator VIII/análise , Fibrinogênio/análise , Hemofilia A/sangue , Humanos , Hipertireoidismo/sangue , Masculino , Metionina/sangue , Propranolol/farmacologia , Selênio , Tiroxina/farmacologia , Doenças de von Willebrand/sangueRESUMO
Aspirin treatment of cultured endothelial cells from the umbilical vein increased the adherence of 51Cr-platelets when thrombin was present. If the cyclooxygenase activity of endothelium was inhibited by aspirin, as it is in the platelet, reduction of endogenous prostacyclin (PGI2) production could have been responsible. By correlating thrombin-induced adherence of platelets to endothelial monolayers with PGI2 release (as measured by radioimmunoassay for 6-keto-prostaglandin FI1 alpha [6-keto-PGF1 alpha]), we have demonstrated an inverse relationship between platelet adherence and PGI2 levels. Untreated endothelial monolayers exposed to thrombin and platelets resulted in 4% platelet adherence and 107 nM 6-keto-PGF1 alpha. With 0.1 mM aspirin treatment, which is known to block platelet cyclooxygenase, adherence was 5% and 6-keto-PGF1 alpha decreased to 45 nM. Increasing the aspirin concentration to 1 mM resulted in 44% adherence and less than 3 nM 6-keto-PGF1 alpha. When 25 nM exogenous PGI2 was added to 1 mM aspirin-treated endothelium, adherence returned to 5%. The increase in thrombin-induced platelet adherence to 1 mM aspirin-treated monolayers was reversed 2 h after removal of the aspirin solution. 6-Keto-PGF1 alpha returned to 37% of the untreated monolayer value. Recovery from the aspirin effect did not occur when cycloheximide, an inhibitor of protein synthesis, was present during the 2-h period.
Assuntos
Aspirina/farmacologia , Endotélio/fisiologia , Epoprostenol/farmacologia , Adesividade Plaquetária/efeitos dos fármacos , Prostaglandinas/farmacologia , Endotélio/metabolismo , Humanos , Técnicas In Vitro , Prostaglandinas F/metabolismo , Trombina/farmacologiaRESUMO
The adhesive characteristics of cultured acute lymphocytic leukemia cells (CCRF-CEM), lymphoma cells (Raji), and freshly isolated acute lymphocytic leukemia cells to human cultured endothelial cells were studied. An assay system was used whereby these neoplastic cells were allowed to interact with endothelial cells while being continuously agitated on a rocking platform. All cell lines adhered significantly to the endothelium monolayers. This process appeared not to be dependent upon intact microtubular or microfilament function. Likewise, removing surface sialic acid from either cell type did not alter this process. In contrast incubating the endothelial cells for 24 or 48 hr with dexamethasone decreased adhesiveness of either CCRF-CEM or Raji cells to the endothelial cells by approximately 40%. Incubating these cells with hydrocortisone instead of dexamethasone for 48 hr was equally as effective in altering the endothelial cell adhesiveness. The decreased adhesiveness could be blocked by cycloheximide, indicating that this altered adhesiveness of the endothelial cells involves protein synthesis, presumably of a surface protein. We suggest that this assay system may provide a means to evaluate other agents that can alter the surface characteristics of endothelial cells, which may have important implications in various disease states such as inflammation, thrombogenesis, and metastatic disease.
Assuntos
Adesão Celular/efeitos dos fármacos , Dexametasona/farmacologia , Endotélio/efeitos dos fármacos , Hidrocortisona/farmacologia , Leucemia Linfoide/patologia , Vasos Sanguíneos/citologia , Linhagem Celular , Colchicina/farmacologia , Endotélio/citologia , Humanos , Técnicas In Vitro , Linfoma/patologia , Metástase Neoplásica , Neoplasias Experimentais/patologia , Células Neoplásicas Circulantes , Neuraminidase/farmacologia , Pronase/farmacologia , Vimblastina/farmacologiaRESUMO
Transgenic mice with macrophage-specific expression of human (hu) lipoprotein lipase (LPL) were generated to determine the contribution of macrophage LPL to atherogenesis. Macrophage specificity was accomplished with the scavenger receptor A promoter. Complete characterization demonstrated that macrophages from these mice expressed huLPL mRNA and secreted enzymatically active huLPL protein. Expression of huLPL was macrophage specific, because total RNA isolated from heart, thymus, lung, liver, muscle, and adipose tissues was devoid of huLPL mRNA. Macrophage-specific expression of huLPL did not exacerbate lesions in aortas of C57BL/6 mice even after 32 weeks on an atherosclerotic diet. However, when expressed in apolipoprotein E knockout background, the extent of occlusion in the aortic sinus region of male huLPL+ mice increased 51% (n=9 to 11, P<0.002) compared with huLPL- mice after they had been fed a Western diet for 8 weeks. The proatherogenic effect of macrophage LPL was confirmed in serial sections of the aorta obtained after mice had been fed a Western diet for 3 weeks. By immunohistochemical analysis, huLPL protein was detected in the lesions of huLPL+ mice but not in huLPL- mice. Our results establish that macrophage LPL accelerates atherosclerosis in male apolipoprotein E knockout mice.
Assuntos
Apolipoproteínas E/genética , Arteriosclerose/etiologia , Lipase Lipoproteica/biossíntese , Macrófagos/metabolismo , Transcrição Gênica , Animais , Arteriosclerose/metabolismo , Arteriosclerose/patologia , Células Cultivadas , Feminino , Humanos , Lipídeos/sangue , Lipase Lipoproteica/genética , Lipase Lipoproteica/fisiologia , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Knockout , Camundongos Transgênicos , RNA Mensageiro/biossíntese , Distribuição TecidualRESUMO
The proliferative activity of a number of intraocular fluids, bovine retinal extract, and normal serum (from humans and cynomolgus monkeys) was investigated by in vitro tissue culture studies, with the use of tritiated thymidine incorporation by the cultured endothelial cells of human umbilical veins. There was increased tritiated thymidine incorporation by (1) the aqueous, vitreous, and intraocular fluid (IOF) (which filled the eye after lensectomy and vitrectomy) removed from cynomolgus monkey eyes with iris neovascularization or with neovascular glaucoma (NVG) that developed after experimental retinal vein occlusion, (2) by aqueous and vitreous removed from human eyes with NVG or proliferative diabetic retinopathy; (3) by the serum, and (4) by the bovine retinal extract. However, tritiated thymidine incorporation was not increased by the normal aqueous, vitreous, or IOF.
Assuntos
Iris/irrigação sanguínea , Neovascularização Patológica/fisiopatologia , Animais , Humor Aquoso/fisiologia , Bovinos , Constrição , Técnicas de Cultura , Glaucoma/fisiopatologia , Humanos , Cristalino/cirurgia , Macaca fascicularis , Retina/fisiologia , Veia Retiniana , Extratos de Tecidos , Vitrectomia , Corpo Vítreo/fisiologiaAssuntos
Epoprostenol/biossíntese , Ácidos Graxos Essenciais/metabolismo , Músculo Liso Vascular/metabolismo , Prostaglandinas/biossíntese , Disponibilidade Biológica , Células Cultivadas , Endotélio/metabolismo , Humanos , Ácido Linoleico , Ácidos Linoleicos/metabolismo , Lipídeos/biossíntese , Ácido Oleico , Ácidos Oleicos/metabolismoAssuntos
Lipase Lipoproteica/metabolismo , Lipoproteínas VLDL/metabolismo , Receptores Imunológicos/metabolismo , Receptores de LDL/metabolismo , Sítios de Ligação , Transporte Biológico , Células Cultivadas , Fibroblastos/citologia , Fibroblastos/metabolismo , Humanos , Lipase Lipoproteica/genética , Proteína-1 Relacionada a Receptor de Lipoproteína de Baixa Densidade , Fragmentos de Peptídeos/genética , Fragmentos de Peptídeos/metabolismo , Ligação Proteica , Proteínas Recombinantes/metabolismo , Relação Estrutura-AtividadeAssuntos
Antígenos/isolamento & purificação , Endopeptidases/farmacologia , Fibrina/imunologia , Fibrinogênio/imunologia , Fibrinólise/efeitos dos fármacos , Ativador de Plasminogênio Tipo Uroquinase/farmacologia , Aminocaproatos/farmacologia , Animais , Aprotinina/farmacologia , Humanos , Soros Imunes/biossíntese , Imunoquímica , Imunoeletroforese , Precipitinas/isolamento & purificação , Coelhos/imunologia , Estreptoquinase/farmacologia , Temperatura , Trombina/farmacologia , Fatores de TempoAssuntos
Epoprostenol/metabolismo , Prostaglandinas/metabolismo , Trombina/farmacologia , Veias Umbilicais/metabolismo , Batroxobina/farmacologia , Relação Dose-Resposta a Droga , Endotélio/citologia , Humanos , Isoflurofato/farmacologia , Peptídeo Hidrolases/farmacologia , Radioimunoensaio , Venenos de Serpentes/farmacologia , Fatores de TempoRESUMO
The effects of hydrocortisone, dexamethasone and prednisone on the morphology, replication, DNA synthesis, cell protein content and protein synthesis of cultured, human endothelial cells were evaluated. After culturing the cells with these glucocorticoids for 24-48 h, the cells covered a greater portion of the culture surface area. The mean surface area of the individual endothelial cell treated with glucocorticoids was 1.53 times greater than that of the untreated control endothelial cell. When compared with controls, the endothelial cover provided by the cells treated with glucocorticoids was more extensive and in many instances covered the entire culture surface. The change in morphology was associated with an increase in protein synthesis and protein content of the cells without an increase in DNA synthesis or cellular replication. Dexamethasone was approximately 10-fold more effective than hydrocortisone, while prednisone was the least effective. Aldosterone, DOCA, testosterone, progesterone, oestradiol and oestriol were ineffective. These studies indicate that glucocorticoids can alter the morphology and biochemistry of cultured endothelial cells and may have implications for the effects of steroids in the treatment of thrombocytopenic states and vascular disorders in man.
Assuntos
Endotélio/efeitos dos fármacos , Glucocorticoides/farmacologia , Células Cultivadas , DNA/biossíntese , Endotélio/citologia , Endotélio/metabolismo , Humanos , Mitose/efeitos dos fármacos , Biossíntese de ProteínasRESUMO
Thrombin is a potent stimulus for prostacyclin (PGI2) release from the vascular endothelium. Treatment of the endothelium with high concentrations of aspirin to block PGI2 formation was associated with increased platelet adherence in a system employing thrombin and 51Cr-labeled platelets. Addition of exogenous PGI2 to the aspirin-treated endothelium restored platelet adherence to the low baseline values. After an initial exposure of the endothelium to thrombin, the cultured endothelium was unable to respond to a second thrombin stimulus with release of PGI2. During this refractory period, the absence of PGI2 was associated with increased platelet adherence. Thus thrombin, an active coagulant and thrombogenic substance, has the capability to release PGI2, the most potent inhibitor of platelet aggregation known to exist in vivo.
Assuntos
Plaquetas/fisiologia , Vasos Sanguíneos/fisiologia , Trombina/fisiologia , Aspirina/farmacologia , Endotélio/efeitos dos fármacos , Endotélio/fisiologia , Epoprostenol/metabolismo , Hemostasia , Humanos , Adesividade Plaquetária/efeitos dos fármacos , Agregação Plaquetária/efeitos dos fármacos , Antagonistas de Prostaglandina/farmacologiaRESUMO
To determine the kinetics of human low density lipoproteins (LDL) interacting with LDL receptors, 125I-LDL binding to cultured human fibroblasts at 4 degrees C was studied. Apparent association rate constants did not increase linearly as 125I-LDL concentrations were increased. Instead, they began to plateau which suggested that formation of initial receptor-ligand complexes is followed by slower rearrangement or isomerization to complexes with higher affinity. To test this, 125I-LDL were allowed to associate for 2, 15, or 120 min, then dissociation was followed. The dissociation was biphasic with the initial phase being 64-110-fold faster than the terminal phase. After binding for 2 min, a greater percentage of 125I-LDL dissociated rapidly (36%) than after association for 15 min (24%) or 120 min (11%). Neither the rate constants nor the relative amplitudes of the two phases were dependent on the degree of receptor occupancy. Thus, the duration of association, but not the degree of receptor occupancy affected 125I-LDL dissociation. To determine if binding by large LDL, which is predominantly via apolipoprotein (apo) E, also occurs by an isomerization mechanism, the d = 1.006-1.05 g/ml lipoproteins were fractionated by ultracentrifugation. In contrast to small LDL which bound via apoB-100 and whose dissociation was similar to that of unfractionated LDL, large LDL dissociation after 2, 15, or 120 min of binding did not show isomerization to a higher affinity. This suggests that large and small LDL bind by different mechanisms as a result of different modes of interaction of apoE and apoB-100 with LDL receptors.
Assuntos
Apolipoproteínas B/metabolismo , Receptores de LDL/metabolismo , Apolipoproteína B-100 , Apolipoproteínas E/metabolismo , Cátions Bivalentes , Células Cultivadas , Fibroblastos/metabolismo , Humanos , Radioisótopos do Iodo , Isomerismo , CinéticaRESUMO
Low density lipoproteins (LDL) are large (Mr = 2.5 x 10(6)) in comparison to LDL receptors (Mr = 115,000). Since most LDL receptors are clustered in coated pits, we tested the hypothesis that crowding of receptor-bound LDL particles would cause steric effects. The apparent affinity of LDL for receptors on cultured fibroblasts decreased near saturation causing concave-upward Scatchard plots. Both the higher and lower affinity components of binding were up-regulated by the cholesterol synthesis inhibitor, lovastatin, indicating that the entire binding curve was sterol-responsive. In contrast, neither component of LDL binding was present on lovastatin-treated or untreated null fibroblasts which are incapable of expressing LDL receptors. Therefore, the concave-upward Scatchard plots were entirely due to binding to LDL receptors. These results are consistent with a lattice model in which receptor-bound LDL are large enough to decrease binding to adjacent receptors. A lattice model implies that large LDL should produce steric effects at a lower receptor occupancy than should small LDL. This was tested using seven LDL fractions that differed in diameter from 20 to 27 nm. Fewer large than small LDL were bound to the cell surface at 4 degrees C and 37 degrees C, and fewer were internalized and degraded at 37 degrees C. Since large LDL bound via both apolipoprotein (apo) E and apoB100, receptor cross-linking could have caused fewer large LDL to be bound at saturation. However, when the potential for cross-linking was prevented by an apo-E-specific monoclonal antibody (1D7), the difference in binding by large versus small LDL was not eliminated; instead, it was exaggerated. Taken together, these results support a lattice model for LDL binding and indicate that steric hindrance associated with crowding of LDL particles on receptor lattices is a major determinant for catabolism by the LDL receptor pathway in vitro.